Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CHMP recommendation
Pharma
EU regulators offer post-mortem of Tavneos withdrawal decision
EU regulators have outlined concerns that led to last week's formal revocation of the marketing authorization for the rare-disease med Tavneos.
Fraiser Kansteiner
Aug 14, 2026 11:04am
Europe's CHMP reverses endorsement of Amgen's Tavneos
Jun 26, 2026 11:07am
EU regulator recommends AZ's Etcamah, Novo's Wegovy pill
May 22, 2026 11:58am
With EU backing, Sanofi gains long-awaited win for tolebrutinib
Apr 24, 2026 11:30am
CHMP gives thumbs up to Moderna's COVID-19, flu combo vaccine
Feb 27, 2026 11:55am
CHMP backs 6 new meds, will probe Amgen's Tavneos
Jan 30, 2026 12:00pm
